Increased exposure to artificial light at night is linked to higher stress-related activity in the brain, more inflammation in the arteries, and an increased risk for heart disease.
It’s the first study to show a PCSK9 inhibitor can reduce major events in high-risk patients who haven’t yet had one.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback